Literature DB >> 9399647

Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair.

D Schwartz1, N Almog, A Peled, N Goldfinger, V Rotter.   

Abstract

Upregulation of the p53 protein was shown to induce cell cycle arrest at the G1/S border and in some cases at the G2/M border. Furthermore, it was suggested that p53 is associated with the induction of the various DNA repair pathways. Previously, we demonstrated that cells co-expressing endogenous wild type p53 protein, together with dominant negative mutant p53, exhibit deregulation of apoptosis, G1 arrest and delay in G2 following gamma-irradiation. In the present study, we investigated the role of p53 protein in the DNA damage response at the G2 phase. Using p53-null, wild type p53 and mutant p53-producer cell lines, we found that the two C-terminally spliced p53 forms could prevent gamma-irradiation induced mutagenesis prior to mitosis, at the G2/M checkpoint. We found that at the G2 phase, p53 may facilitate repair of DNA breaks giving rise to micronuclei, and regulate the exit from the G2 checkpoint. At the G1 phase, only the regularly spliced form of p53 caused growth arrest. In contrast, both the regularly and the alternatively spliced p53 forms directed postmitotic micronucleated cells towards apoptosis. These results provide a functional explanation for the cell cycle-independent expression of p53 in normal cycling cells, as well as in cells where p53 is up-regulated, following DNA damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399647     DOI: 10.1038/sj.onc.1201436

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.

Authors:  Hui Tian; Alexander T Faje; Siu Lan Lee; Timothy J Jorgensen
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

2.  Processing of bistranded abasic DNA clusters in gamma-irradiated human hematopoietic cells.

Authors:  Alexandros G Georgakilas; Paula V Bennett; David M Wilson; Betsy M Sutherland
Journal:  Nucleic Acids Res       Date:  2004-10-19       Impact factor: 16.971

3.  Role of inducible heat shock protein 70 in radiation-induced cell death.

Authors:  S J Lee; S A Choi; K H Lee; H Y Chung; T H Kim; C K Cho; Y S Lee
Journal:  Cell Stress Chaperones       Date:  2001-07       Impact factor: 3.667

4.  Tumor suppressive function of microRNA-192 in acute lymphoblastic leukemia.

Authors:  Mahtab Sayadi; Soheila Ajdary; Fatemeh Nadali; Shahrbano Rostami; Mahdi Edalati Fahtabad
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

5.  Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death.

Authors:  Nancy McLaughlin; Borhane Annabi; Marie-Paule Lachambre; Kwang Sik Kim; Jean-Paul Bahary; Robert Moumdjian; Richard Béliveau
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

6.  Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs.

Authors:  X Jiang; L Y Lim; J W Daly; A H Li; K A Jacobson; M Roberge
Journal:  Int J Oncol       Date:  2000-05       Impact factor: 5.650

7.  A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides.

Authors:  M L Agarwal; A Agarwal; W R Taylor; O Chernova; Y Sharma; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells.

Authors:  Chandramu Chetty; Praveen Bhoopathi; Jasti S Rao; Sajani S Lakka
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

9.  Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.

Authors:  H M Warenius; M Jones; T Gorman; R McLeish; L Seabra; R Barraclough; P Rudland
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.